Demant A/S (VIE:DEMA)

Market Cap	5.52B -22.4%
Revenue (ttm)	3.08B +2.5%
Net Income	206.87M -35.3%
EPS	0.98 -33.5%
Shares Out	n/a
PE Ratio	26.68
Forward PE	15.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	22
Open	25.80
Previous Close	26.18
Day's Range	25.72 - 25.88
52-Week Range	23.50 - 39.12
Beta	n/a
RSI	54.04
Earnings Date	Aug 11, 2026

About Demant

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1904
• Employees: 26,704
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DEMA

Financial Performance

In 2025, Demant's revenue was 22.97 billion, an increase of 2.46% compared to the previous year's 22.42 billion. Earnings were 1.55 billion, a decrease of -35.27%.

Financial numbers in DKK